摘要
目的了解我院口服抗高血压药物的应用情况,为临床合理用药提供参考。方法采用限定日剂量分析方法,对我院2009～2011年口服抗高血压药物的药品名称、销售金额、用药频度、日均费用等指标进行统计分析。结果近3年我院住院患者使用抗高血压药物销售金额前3位一直是钙离子拮抗剂(CCB)、血管紧张素受体阻滞剂(ARB)、血管紧张素转换酶抑制剂(ACEⅠ);用药频度前3位一直是CCB、利尿剂、ARB;单品种排序中销售金额前2位一直是硝苯地平控释片(拜心同)、氨氯地平片(络活喜),第3位2009年为左旋氨氯地平片,后由培哚普利片(雅施达)替代;用药频度前3位一直是硝苯地平控释片、氨氯地平片和螺内酯片。结论我院口服抗高血压药物使用基本合理。
Objective To investigate the application of oral antihypertensive drugs in our hospital,provide reference for clinical rational drug use. Methods By using the defined daily dose analysis method, drug name,sales amount, DDDs, daily expense and other indicators of oral antihypertensive drugs in our hospital from 2009 to 2011 were counted and analyzed. Re- suits The top sales amount antihypertensive drugs were calcium channel blockers （CCB）, angiotelasin [l receptor blockers （ARB）, angiotensin-converting enzyme inhibitors （ACE I）; the top DDDs were CCB, diuretics, A]？tB;single species sorted sales amount in the top 2 were nifedipine controlled-release tablets （Adalat）,amlodipine besylate tablets （Norvasc）,the third in 2009 for levo-amlodipine tablets, by perindopril tablets （Acertil） replacement; the top there DDDs were nifedipine controlled- release,amlodipine tablets and spironolaetone tablets. Conclusion The use of oral antihypertensive drugs in our hospital is basically rational.
出处
《中国现代医药杂志》
2012年第7期17-19,共3页
Modern Medicine Journal of China
